Comparison of toxicity and outcomes of concurrent radiotherapy with carboplatin/paclitaxel or cisplatin/etoposide in stage III non–small cell lung cancer-Reference-Cited by-同舟云学术

Comparison of toxicity and outcomes of concurrent radiotherapy with carboplatin/paclitaxel or cisplatin/etoposide in stage III non–small cell lung cancer

Published:2013-10-16 Issue:6 Volume:2 Page:916-924
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Liew Mun Sem¹²³⁴,Sia Joseph⁵,Starmans Maud H. W.⁶⁷,Tafreshi Ali¹,Harris Sam¹,Feigen Malcolm⁵,White Shane¹,Zimet Allan¹,Lambin Philippe⁷,Boutros Paul C.⁶,Mitchell Paul¹,John Thomas¹²

Affiliation:

1. Austin‐Ludwig Oncology Unit Olivia Newton‐John Cancer and Wellness Centre Austin Health Melbourne Australia

2. Ludwig Institute for Cancer Research Olivia Newton‐John Cancer & Wellness Centre Austin Health Melbourne Australia

3. Department of Medicine Austin Health Melbourne Australia

4. University of Melbourne Melbourne Australia

5. Department of Radiation Oncology Olivia Newton‐John Cancer & Wellness Centre Austin Health Melbourne Australia

6. Informatics and Biocomputing Platform Ontario Institute for Cancer Research Toronto Canada

7. Department of Radiation Oncology (Maastro) GROW‐School for Oncology and Developmental Biology Maastricht University Medical Center Maastricht the Netherlands

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.142

Reference34 articles.

1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

2. Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Mitomycin, Vindesine, and Cisplatin in Unresectable Stage III Non–Small-Cell Lung Cancer

3. Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410

4. Concurrent chemoradiotherapy in non‐small cell lung cancer;O'Rourke N.;Cochrane Database Syst. Rev.,2010

5. Emerging developments of chemoradiotherapy in stage III NSCLC

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of post-chemoradiotherapy pneumonitis between Asian and non-Asian patients with locally advanced non-small cell lung cancer: a systematic review and meta-analysis;eClinicalMedicine;2023-10

2. Optimization of diagnostic and therapeutic management in patients with stage III non-small cell lung cancer — experience of the centers in Poznań;Oncology in Clinical Practice;2023-06-29

3. Significant Contribution of Interleukin-18 Genotypes to Lung Cancer Risk in Taiwanese;Anticancer Research;2022-07

4. A network meta-analysis for efficacies and toxicities of different concurrent chemoradiotherapy regimens in the treatment of locally advanced non-small cell lung cancer;BMC Cancer;2022-06-20

5. Efficacy of platinum agents for stage III non-small-cell lung cancer following platinum-based chemoradiotherapy: a retrospective study;BMC Cancer;2022-03-29